- Cue Health’s Covid-19 tests may be providing false results, the Food and Drug Administration (FDA) recently warned consumers. The FDA recently sent a warning letter to the company that runs the convenient — but pricey — over-the-counter testing system, stating Cue Health was not following the conditions outlined in the Emergency Use Authorizations for its tests. “Report any problems you experience with the Cue Health COVID-19 Test for Home and Over the Counter (OTC) Use to the FDA, including suspected false positive or false negative results,” the agency wrote. Read more in STAT News.
- A new study in The Lancet has found a “striking discrepancy” between self-reported Long Covid cases and those in electronic health care records in England, suggesting that the disease is likely vastly undercounted. The study looked at over 6,450 records and found 896 people self-reported Long Covid, yet of those who self-reported, only 48 had the diagnosis on their official record. “This finding might reflect substantial unmet clinical need, in keeping with reports from individuals with Long Covid of difficulties accessing health care and suboptimal recognition of and response to their illness when they do,” the authors wrote. Read more about the study in Long Covid Weekly.
- A clinical trial in Bethesda, Maryland is recruiting six people to study the radiotracer drug, [11C]CPPC, to see if it can be used to make better images of the brain and increase understanding of Long Covid using imaging technology including magnetic resonance imaging (MRI). Radiotracers, also known as radiopharmaceuticals, are small amounts of radioactive material used in nuclear medicine to diagnose and treat disease, including cancer, heart disease, and neurological disorders. Read more about the trial here and follow Long Covid Studies for the most up-to-date clinical trials.
Leave a Reply